Global Excipients Market is valued at approximately USD 9.89 billion in 2023 and is projected to grow at a CAGR of 4.03% over the forecast period 2024-2032. Excipients—substances formulated alongside the active ingredients in pharmaceuticals—play a pivotal role in ensuring drug stability, bioavailability, and controlled release. As pharmaceutical innovation surges forward, the demand for novel excipients that can support new drug formulations has grown tremendously. These often-overlooked components are essential in enhancing solubility, ensuring consistency in drug delivery, and prolonging shelf life. With the expansion of both generic and specialty drugs, the excipients market is rapidly adapting to the demands of advanced therapeutics and customized treatment protocols, reinforcing its foundational role in modern drug development.
The market growth is underpinned by the evolving pharmaceutical landscape, where oral solid dosage forms continue to dominate, yet more sophisticated formulations—like modified-release systems and biologics—are driving demand for more specialized excipient solutions. Functional innovations in excipients, such as co-processed excipients or multifunctional polymers, are enabling better compressibility, improved taste masking, and enhanced drug stability. Regulatory encouragement for patient-centric formulations and the increasing use of biopharmaceuticals further stimulate the need for high-performance excipients. However, challenges remain, particularly surrounding the regulatory approval of novel excipients and the risk associated with their limited toxicological history. These hurdles can impede their adoption in mainstream pharmaceutical manufacturing, especially in cost-sensitive markets.
From the standpoint of product categories, polymers continue to dominate the excipients market owing to their extensive application in controlled and sustained-release drug formulations. Gelatin and alcohol-based excipients are also widely adopted due to their solubilizing and binding properties. Among formulations, the oral segment leads due to its ease of administration, patient compliance, and cost-effectiveness. Meanwhile, the topical formulation segment is growing steadily, driven by rising demand in dermatological and cosmetic applications. Functionally, binders hold the lion’s share of the market, closely followed by coating agents which help improve drug stability and provide masking of unpleasant tastes and odors.
Geographically, North America commands the largest share of the global excipients market, bolstered by the region’s robust pharmaceutical infrastructure, consistent regulatory oversight, and substantial R&D investments. The United States continues to spearhead innovation in formulation technologies and maintains a large base of pharmaceutical manufacturing. Europe follows closely, benefiting from well-established manufacturing hubs in countries like Germany, Switzerland, and the UK. The Asia Pacific region is anticipated to witness the fastest growth, driven by expanding generic drug production, rising healthcare expenditure, and increasing government support in India, China, and South Korea. Latin America and the Middle East & Africa are also poised for steady growth as pharmaceutical industries in these regions mature and global players expand their footprint.
Major market player included in this report are:
• BASF SE
• DuPont de Nemours, Inc.
• Evonik Industries AG
• Ashland Global Holdings Inc.
• Roquette Frères
• Croda International Plc
• Associated British Foods plc
• The Dow Chemical Company
• Lubrizol Corporation
• Kerry Group plc
• Archer Daniels Midland Company
• Merck KGaA
• Colorcon Inc.
• Wacker Chemie AG
• JRS Pharma GmbH & Co. KG
The detailed segments and sub-segmens of the market are explained below:
By Product
• Polymers
• Alcohols
• Sugars
• Minerals
• Gelatin
By Formulation
• Oral
• Topical
By Function
• Binders
• Coating Agents
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook